Free Trial

Alpha Teknova (TKNO) Competitors

Alpha Teknova logo
$5.18 +0.01 (+0.19%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$5.25 +0.07 (+1.35%)
As of 07/25/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TKNO vs. NRIX, QURE, SNDX, TRVI, MENS, NAGE, XERS, NUVB, MAZE, and CRON

Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Nurix Therapeutics (NRIX), uniQure (QURE), Syndax Pharmaceuticals (SNDX), Trevi Therapeutics (TRVI), Jyong Biotech (MENS), Niagen Bioscience (NAGE), Xeris Biopharma (XERS), Nuvation Bio (NUVB), Maze Therapeutics (MAZE), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

Alpha Teknova vs. Its Competitors

Nurix Therapeutics (NASDAQ:NRIX) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

Nurix Therapeutics has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500.

Alpha Teknova has a net margin of -60.90% compared to Nurix Therapeutics' net margin of -234.57%. Alpha Teknova's return on equity of -28.48% beat Nurix Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Nurix Therapeutics-234.57% -45.26% -34.71%
Alpha Teknova -60.90%-28.48%-19.73%

13.8% of Alpha Teknova shares are held by institutional investors. 7.4% of Nurix Therapeutics shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Alpha Teknova has lower revenue, but higher earnings than Nurix Therapeutics. Alpha Teknova is trading at a lower price-to-earnings ratio than Nurix Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nurix Therapeutics$88.38M9.96-$193.57M-$2.61-4.41
Alpha Teknova$37.74M7.33-$26.75M-$0.48-10.79

In the previous week, Alpha Teknova had 1 more articles in the media than Nurix Therapeutics. MarketBeat recorded 5 mentions for Alpha Teknova and 4 mentions for Nurix Therapeutics. Nurix Therapeutics' average media sentiment score of 1.53 beat Alpha Teknova's score of 0.97 indicating that Nurix Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nurix Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Alpha Teknova
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Nurix Therapeutics currently has a consensus target price of $29.31, indicating a potential upside of 154.45%. Alpha Teknova has a consensus target price of $10.00, indicating a potential upside of 93.05%. Given Nurix Therapeutics' higher probable upside, equities research analysts plainly believe Nurix Therapeutics is more favorable than Alpha Teknova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nurix Therapeutics
0 Sell rating(s)
3 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.82
Alpha Teknova
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Summary

Alpha Teknova beats Nurix Therapeutics on 10 of the 17 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TKNO vs. The Competition

MetricAlpha TeknovaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$276.29M$3.06B$5.69B$9.50B
Dividend YieldN/A2.37%4.58%4.01%
P/E Ratio-10.7921.1828.1020.05
Price / Sales7.33288.50432.4490.07
Price / CashN/A42.7636.2258.56
Price / Book3.348.378.665.87
Net Income-$26.75M-$55.19M$3.25B$258.55M
7 Day Performance21.31%5.88%4.23%3.74%
1 Month Performance1.37%17.33%10.52%11.75%
1 Year Performance26.96%4.42%34.41%18.03%

Alpha Teknova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TKNO
Alpha Teknova
2.2131 of 5 stars
$5.18
+0.2%
$10.00
+93.1%
+45.9%$276.29M$37.74M-10.79240News Coverage
Analyst Upgrade
NRIX
Nurix Therapeutics
2.6575 of 5 stars
$11.25
+0.4%
$29.31
+160.6%
-45.2%$857M$54.55M-4.31300
QURE
uniQure
2.2039 of 5 stars
$14.50
-3.3%
$37.82
+160.8%
+76.3%$821.09M$27.12M-3.30500Upcoming Earnings
SNDX
Syndax Pharmaceuticals
3.5291 of 5 stars
$9.73
+2.9%
$34.10
+250.5%
-60.9%$814.01M$23.68M-2.52110
TRVI
Trevi Therapeutics
3.8823 of 5 stars
$6.82
-0.6%
$20.88
+206.1%
+148.3%$804.63MN/A-15.1620
MENS
Jyong Biotech
N/A$11.00
+4.3%
N/AN/A$802.09MN/A0.0031Quiet Period Expiration
NAGE
Niagen Bioscience
1.447 of 5 stars
$9.68
-4.7%
$13.22
+36.6%
N/A$800.70M$107.93M56.94120
XERS
Xeris Biopharma
4.006 of 5 stars
$5.14
+0.6%
$6.25
+21.6%
+96.5%$799.12M$203.07M-17.13290News Coverage
Positive News
NUVB
Nuvation Bio
2.2113 of 5 stars
$2.36
+2.4%
$7.17
+204.3%
-32.3%$782.60M$7.87M-1.0060News Coverage
Analyst Upgrade
Gap Up
MAZE
Maze Therapeutics
N/A$16.66
-6.3%
$23.50
+41.1%
N/A$778.71M$167.50M0.00121News Coverage
Analyst Forecast
Lockup Expiration
Analyst Revision
Gap Up
High Trading Volume
CRON
Cronos Group
1.9825 of 5 stars
$2.09
+4.0%
N/A-15.3%$775.22M$117.61M16.08450News Coverage

Related Companies and Tools


This page (NASDAQ:TKNO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners